FILTER
FILTERED INTERVIEW RESULTS
Danny Callow
CEO, AFRICAN GOLD GROUP (AGG)
African Gold Group explains its ambitions in West Africa where it’s Kobada gold mine is under construction.
Hon. Leopold Mboli Fatran
MINISTER OF MINES AND GEOLOGY, CENTRAL AFRICAN REPUBLIC (CAR)
GBR speaks to Leopold Mboli Fatran, Minister of Mines and Geology of Central African Republic concerning the challenges of developing the country’s resource industries.
Danny Callow
COO, AFRICAN GOLD GROUP
African Gold Group explains its progress at its Kobada gold project in Mali as it advances towards production.
Nana Bompeh Sangmuah
PRESIDENT & CEO, ROSCAN GOLD
Roscan Gold’s Kandiolé project is located in a highly-prospective district in Mali.
Andrew van Zyl
DIRECTOR, SRK CONSULTING (SA)
SRK Consulting is an international consultancy service provider for the natural resource industry, operating in South Africa, DRC and Ghana.
Ralf Hennecke
GENERAL MANAGER: TECHNOLOGY AND MARKETING, BME
BME offers products and services including explosives, bulk emulsions, initiating systems, technical services and software for surface and underground mining.
Enoch Kusi-Yeboah
GENERAL MANAGER, METSO MINERALS GHANA
From its offices in Ghana, Metso comments on how its offering is developing alongside the West African mining industry.
Kouamé Klemet-N’Guessan
PARTNER, KSK AVOCATS
KSK Avocats, a leading law firm in Côte d’Ivoire involved in the mining industry, explains the regulations related to operating in the country.
Raphael Khalifa
FOUNDER, TEMBO POWER
Tembo Power is developing hydropower projects across Africa with a focus on DRC.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
